http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200714593-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03d0f52bb4069f8a19d70dcfb697c67a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-135
filingDate 2006-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21f228459dee29fe94cdfe638e8604e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ca8394237211984d955d889f51bf6a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f22f0e760398aa7dc9233b992a415ab0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8efbf52f4547162f4f57f6f770a62257
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe1039b0df151cce01c68a91795c8f3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f20eb56c112b73766b7a7a3063e5fae5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29d37fb863a4a01dea67531e7bf9d648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee5c75ef27ef53d8cd5cf4861d5378c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a821f98f8f527da87c851a7ef202526f
publicationDate 2007-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-200714593-A
titleOfInvention Agent for treatment of solid tumor
abstract Disclosed is an agent for treatment and/or prevention of solid tumors which contains a thiadiazoline derivative represented by the general formula (I) below or a pharmacologically acceptable salt thereof. [In the formula, n represents an integer of 1-3; R1 represents a hydrogen atom and R2 represents a lower alkyl group, or alternatively R1 and R2 combine together to form an alkylene; R3 represents a lower alkyl; R4 represents NHSO2R6 (wherein R6 represents a hydroxy or the like) or the like; and R5 represents an aryl or the like.]
priorityDate 2005-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 31.